RCKT - Rocket Pharma nabs FDA priority review for gene therapy
2023-10-02 08:40:28 ET
More on Rocket Pharma
- Rocket Pharmaceuticals: Update On RP-A501 Strengthens Bullish Outlook
- Rocket Pharmaceuticals: Soaring On Pivotal Danon Disease Study Agreement - More Upside Ahead?
- Rocket Pharmaceuticals: Thriving Gene Therapy With Multiple Catalysts
- Biggest stock movers today: Grab Holdings, Workhorse Group, Rocket Pharmaceuticals and more
- Rocket rises as FDA supports accelerated path for gene therapy
For further details see:
Rocket Pharma nabs FDA priority review for gene therapy